{"bill": {"#text": "\n  ", "form": {"current-chamber": {"#tail": "\n    ", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n  ", "legis-num": {"#tail": "\n    ", "#text": "S. 1657"}, "official-title": {"#tail": "\n  ", "#text": "To reduce prescription drug misuse and\n\t\t  abuse."}, "session": {"#tail": "\n    ", "#text": "1st Session"}, "distribution-code": {"#tail": "\n    ", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n      ", "@date": "20131106", "#text": "November 6, 2013"}, "#tail": "\n    ", "action-desc": {"#tail": "\n    ", "#text": "\n        ", "sponsor": {"#tail": " introduced the following bill; which was read twice and referred to the ", "#text": "Mr. Udall of New Mexico", "@name-id": "S326"}, "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}}, "#text": "\n      "}, "legis-type": {"#tail": "\n    ", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "#text": "Increasing the Safety of\n\t\t\t Prescription Drug Use Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as\n\t\t\t the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Prescription\n\t\t\t drug monitoring program"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is\n\t\t\t amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 399O of the Public Health Service Act", "@value": "Public Health Service Act/s:399O"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 243g\u20133", "@value": "usc/42/243g\u20133"}, "@parsable-cite": "usc/42/243g-3", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Controlled substance monitoring program"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by adding at the end the following:", "@entity-type": "act", "#text": "subsection (e)", "@value": "Public Health Service Act/s:3990/ss:e"}, "#text": "in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "; and"}, "#tail": "\n        ", "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "The\n\t\t\t\tState shall\u2014"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "#text": "\n              ", "@id": "id0053E15B3ED4422AAB1FB807C33D0145", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "ensure that the database\u2014"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "is interoperable\n\t\t\t\twith the controlled substance monitoring program of other States and other Federal agencies and across\n\t\t\t\tappropriate State agencies, including health agencies, as determined by the\n\t\t\t\t"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "#text": "\n                  ", "@id": "id61FC203CD8D64223BFE4264A7DE743E5", "@commented": "no"}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "is interoperable\n\t\t\t\twith electronic health records and e-prescribing, where appropriate; and"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "#text": "\n                  ", "@id": "idB4D49D8D631A4A0B8AA7789B47FBEE18", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "provides\n\t\t\t\tautomatic, real-time or daily information about a patient when a practitioner (or the\n\t\t\t\tdesignee of a practitioner, where permitted) requests information about such\n\t\t\t\tpatient;"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "#text": "\n                  ", "@id": "id962780CF2575402EBD0A7215B433CEEF", "@commented": "no"}], "#text": "\n                ", "@id": "id6A0B686F469D44078A2B28CAFDD6BE58", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "require practitioners to use State database information to help determine \t\t\t\twhether to prescribe or renew a prescription for a controlled \t\t\tsubstance; and"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "idC477291FEFB5461F825CD97A76C09A35", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", including the name of the patient, the date, and prescription\n\t\t\t\tdose, into the database for a controlled substance.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "require\n\t\t\t\tdispensers, or their designees, where permitted, to enter data required by\n\t\t\t\tthe "}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "id9c86689b45a24e528e43b172ea4c4f78", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and any other provision\n\t\t\t\tof law, the data required to be entered under ", "@entity-type": "act", "#text": "section 543", "@value": "Public Health Service Act/s:543"}, {"#tail": " shall\n\t\t\t\tinclude information with respect to methadone that is dispensed to a patient, if applicable.", "@entity-type": "act", "#text": "paragraph (5)(C)", "@value": "Public Health Service Act/s:3990/ss:e/p:5/sp:C", "@proposed": "true"}], "#text": "Notwithstanding "}, "enum": {"#tail": "\n              ", "#text": "(6)"}, "#text": "\n              ", "@id": "id5FAA73674E1C44AD96AF530EDFEF4A86", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "The\n\t\t\t\tState shall ensure that\u2014"}, "enum": {"#tail": "\n              ", "#text": "(7)"}, "#text": "\n              ", "@id": "id5E580816F50444BBB2480CEA2B52C0A1", "@commented": "no", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "any person who\n\t\t\t\treceives patient information through the database may disclose and use\n\t\t\t\tsuch information only to carry out the official duties of that person with regard to\n\t\t\t\tthe patient; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "id6CB59E272CC34AAABABFF27A618ED780", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", no information kept in\n\t\t\t\taccordance with a database developed or maintained through a grant under\n\t\t\t\tthis section may be used to conduct a criminal investigation or substantiate any criminal charges\n\t\t\t\tagainst a patient or to conduct any investigation of a patient relating to methadone use of the patient.", "@entity-type": "act", "#text": "subsection (f)(1)(B)", "@value": "Public Health Service Act/s:3990/ss:f/p:1/sp:B", "@proposed": "true"}, "#text": "notwithstanding "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "id88A7AFA7EE874617BDBF6AF75D5904EE", "@commented": "no"}]}], "@display-inline": "no-display-inline", "#text": "\n            ", "@id": "id61FBC27E85844E1D9C3EBEADD5455CC5"}, "#text": "\n          ", "@id": "id56C2D72968E24DD18DDE436A8565B22E"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking\n\t\t\t ", "@entity-type": "act", "#text": "subsection (n)", "@value": "Public Health Service Act/s:3990/ss:n"}, "#text": "in ", "quote": [{"#tail": " and all that follows through the\n\t\t\t period at the end and inserting ", "#text": "To carry out this section"}, {"#tail": ".", "#text": "\n              ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\n            ", "@entity-type": "auth-auth-approp", "#text": "There are authorized to be appropriated\n\t\t\t for ", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": " ", "#text": "fiscal years 2014 through 2018 such sums as may be necessary", "@amount": "indefinite", "@year": "2014..2018"}, "{http://namespaces.cato.org/catoxml}property": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "act", "#text": "this section", "@value": "Public Health Service Act/s:3990"}, "#text": "to carry out\n\t\t\t ", "@name": "purpose"}}}]}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "id19123347BB114B53A831DB4AB1E18D53", "#text": "\n          "}], "#text": "\n        ", "@id": "idAF3F343F2252493BA7BCAA55FA554B53"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "quote": {"#tail": " before the period at the end.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "section 399O(e)(6)", "@value": "Public Health Service Act/s:399O/ss:e/p:6", "@proposed": "true"}, "#text": "or, with respect to methadone, as required under "}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 543(a) of the Public Health Service Act", "@value": "Public Health Service Act/s:543/ss:a"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 290dd\u20132(a)", "@value": "usc/42/290dd\u20132/a"}, "@parsable-cite": "usc/42/290dd-2", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Confidentiality of records"}, "#text": "\n        ", "@id": "id6A876907A46840FB8A6D18B901259630", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " of such section) who\n\t\t\t\tparticipate in or are employed by a Federal health care program or federally\n\t\t\t\tfunded health care program, including the ", "@entity-type": "act", "#text": "paragraph (4)", "@value": "Public Health Service Act/s:3990/ss:m/p:4"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Indian Health Service", "@entity-id": "7527"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Department\n\t\t\t\tof Veterans Affairs", "@entity-id": "3600"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Department of Defense", "@entity-id": "9700"}, {"#tail": ",\n\t\t\t\tthe Medicare program under ", "@entity-type": "federal-body", "#text": "Federal Bureau of Prisons", "@entity-id": "1540"}], "#text": "Health care practitioners (as defined in ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": ") and dispensers (as defined in ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "paragraph (7) of section 399O(m) of the Public Health Service Act", "@value": "Public Health Service Act/s:399O/ss:m/p:7"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C.  280g\u20133(m)", "@value": "usc/42/280g\u20133/m"}], "@entity-type": "law-citation", "#text": "\n            "}, {"#tail": ", a State Medicaid plan under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "title XVIII of the Social Security Act", "@value": "Social Security Act/t:XVIII"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395 et seq.", "@value": "usc/42/1395/etseq"}, "@parsable-cite": "usc/42/1395", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": ", the Children's Health Insurance\n\t\t\t\tProgram under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "title XIX of the Social Security Act", "@value": "Social Security Act/t:XIX"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1396 et seq.", "@value": "usc/42/1396/etseq"}, "@parsable-cite": "usc/42/1396", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": ", and Federally qualified health centers, shall use the databases of the controlled substance monitoring programs under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "title XXI of the Social Security Act", "@value": "Social Security Act/t:XXI"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 1397aa et seq.", "@value": "usc/42/1397aa/etseq"}, "@parsable-cite": "usc/42/1397aa", "#text": "\n              ", "@legal-doc": "usc"}}, {"#tail": ", if such databases are available to the practitioner or dispenser.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 399O of the Public Health Service Act", "@value": "Public Health Service Act/s:399O"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "42 U.S.C. 280g\u20133", "@value": "usc/42/280g\u20133"}, "@parsable-cite": "usc/42/280g-3", "#text": "\n              ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Requirements\n\t\t\t\tfor Federal health care programs"}, "#text": "\n        ", "@id": "idCB3C54F9A54E45309612F0E936521CD7", "@commented": "no"}], "#text": "\n      ", "@id": "idDE56035718AE41E8948CBB8132164FA6"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Pilot\n\t\t\t\tproject"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (referred to in this subsection as the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "quote": [{"#tail": ") shall award grants to one or more States to\n\t\t\t\tcarry out a 1-year pilot project to develop a standardized peer review process\n\t\t\t\tand methodology to review and evaluate prescribing and pharmacy dispensing\n\t\t\t\tpatterns, through a review of prescription drug monitoring programs (referred to in this section as ", "#text": "Secretary"}, {"#tail": ") in the\n\t\t\t\tStates receiving such grants.", "#text": "PDMP"}]}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n        ", "@id": "idFD837F5F399A4E318E295FAC60628077", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n      ", "#text": "The\n\t\t\t\trecipients of a grant under this section shall develop a systematic,\n\t\t\t\tstandardized methodology to identify and investigate questionable or\n\t\t\t\tinappropriate prescribing and dispensing patterns of substances on schedule II\n\t\t\t\tor III under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ". Such peer review\n\t\t\t\tmethodology and prescribing and dispensing patterns shall be shared with the appropriate State health\n\t\t\t\tprofession board.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 202 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 812", "@value": "usc/21/812"}, "@parsable-cite": "usc/21/812", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Methodology"}, "#text": "\n        ", "@id": "id3A143947F2A540218ADDFEEE32742278", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "A\n\t\t\t\tState receiving a grant under this section shall\u2014"}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Requirements"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in order to prescribe such controlled substances, make the\n\t\t\t\tinformation with respect to such controlled substances from the PDMP available to State\n\t\t\t\tregulation and licensing boards; and", "@entity-type": "federal-body", "#text": "Drug\n\t\t\t\tEnforcement Administration", "@entity-id": "1524"}, "#text": "with respect to\n\t\t\t\tcontrolled substances  for which a prescriber is required to have a license issued by the "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "id21BC0F4204E94F10BE12F0B4946373DB", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "with respect to\n\t\t\t\tany other controlled substances, may make the information with respect to such controlled substances from the\n\t\t\t\tPDMP available to State regulation and licensing boards."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "idB87CC7129C2946FC8EFC413ADD93E794", "@commented": "no"}], "#text": "\n        ", "@id": "idAEB65C76208142D1987EE14B4BE63287", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " has entered into a\n\t\t\t\tcontract under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " may serve as the\n\t\t\t\tsubgrantee under this subsection to develop peer review processes as described\n\t\t\t\tin ", "@entity-type": "act", "#text": "part B of title XI of the Social Security Act", "@value": "Social Security Act/t:XI/pt:B"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection\n\t\t\t\t(a)", "@value": "Increasing the Safety of Prescription Drug Use Act of 2013/s:3/ss:a", "@proposed": "true"}], "#text": "A\n\t\t\t\tquality improvement organization with which the "}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Subgrantees"}, "#text": "\n        ", "@id": "idD18C25E894924BF68523C0E491ABD7FF", "@commented": "no"}], "#text": "\n      ", "@id": "id2F1791E3E0FE419DBEA1293DF0DFE9E6", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end\n\t\t\t the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Part P of title III of\n\t\t\t the Public Health Service Act", "@value": "Public Health Service Act/t:III/pt:P"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C. 280g", "@value": "usc/42/280g"}, "@parsable-cite": "usc/42/280g", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n      ", "#text": "Prescription\n\t\t\t drug and other controlled substance abuse prevention"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n    ", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "399V\u20136."}, "header": {"#tail": "\n          ", "#text": "Prescription\n\t\t\t\tdrug and other controlled substance abuse prevention"}, "subsection": [{"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "Training\n\t\t\t\tgrants"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall award 5-year grants to eligible\n\t\t\t\tentities to facilitate training in order to increase the capacity of health\n\t\t\t\tcare providers to conduct patient screening and brief interventions, such as in health\n\t\t\t\tcare settings to prevent the abuse of prescription drugs and other controlled substances. The grant program under this section may be coordinated with the Screening Brief Intervention and Referral to Treatment grant program of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", or other appropriate program.", "@entity-type": "federal-body", "#text": "Substance Abuse and Mental Health Services Administration", "@entity-id": "7522"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "id69488762CF144E06BEAE25282F217335", "@commented": "no"}, {"#tail": "\n          ", "@id": "idDF0CF0A5A9344A5EA00B23AB615779C0", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Eligible\n\t\t\t\tentities"}, "text": {"#tail": "\n              ", "quote": {"#tail": " includes\u2014", "#text": "eligible\n\t\t\t\tentity"}, "#text": "In this subsection, the term "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "States;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "id0C7F127A3D2342B29A59639AF5693645", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "continuing\n\t\t\t\teducation entities, such as health profession boards or health accrediting\n\t\t\t\tbodies; and"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "id4AF507EABC6C409DB880D25E13189D5B", "@commented": "no"}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "other appropriate\n\t\t\t\thealth or professional education organizations or institutions."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "#text": "\n                ", "@id": "id143198681E304F70AEEF027B704F3521", "@commented": "no"}], "@commented": "no"}], "#text": "\n            ", "@id": "id0A3E2BEF8661466A90D2B177F8A54650", "@commented": "no"}, {"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "federal-body", "#text": "Indian Health\n\t\t\t\tService", "@entity-id": "7527"}, {"#tail": ", the ", "@entity-type": "federal-body", "#text": "Department of Veterans Affairs", "@entity-id": "3600"}, {"#tail": ", the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Department of Defense", "@entity-id": "9700"}, {"#tail": ", the Medicare program under ", "@entity-type": "federal-body", "#text": "Federal Bureau of Prisons", "@entity-id": "1540"}], "#text": "Health care providers who participate in or are\n\t\t\t\temployed by a Federal health care program, including the ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": ", a State Medicaid plan under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "title XVIII of the Social\n\t\t\t\tSecurity Act", "@value": "Social Security Act/t:XVIII"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395 et seq.", "@value": "usc/42/1395/etseq"}, "@parsable-cite": "usc/42/1395", "#text": "\n                  ", "@legal-doc": "usc"}}, {"#tail": ", the State Children's Health\n\t\t\t\tInsurance Program under ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "title XIX of\n\t\t\t\tthe Social Security Act", "@value": "Social Security Act/t:XIX"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                ", "@entity-type": "uscode", "#text": "42 U.S.C. 1396 et seq.", "@value": "usc/42/1396/etseq"}, "@parsable-cite": "usc/42/1396", "#text": "\n                  ", "@legal-doc": "usc"}}, {"#tail": ", and Federally qualified health centers, shall screen patients for\n\t\t\t\tabuse of prescription drugs or other controlled substances, conduct brief interventions, and provide referrals for\n\t\t\t\tknown or suspected abuse of prescription drugs or other controlled substances, as appropriate.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "title XXI of the Social Security Act", "@value": "Social Security Act/t:XXI"}, {"#tail": ")", "@entity-type": "uscode", "#text": "42 U.S.C. 1397aa\n\t\t\t\tet seq.", "@value": "usc/42/1397aa/etseq"}], "@entity-type": "law-citation", "#text": "\n                "}]}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Federal health\n\t\t\t\tcare workers"}, "#text": "\n            ", "@id": "id2D6644BCEA8B40E8B9CC2AFBA1A7662E", "@commented": "no"}, {"#tail": "\n        ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ", shall award grants to States for\n\t\t\t\tthe purpose of evaluating the prospect of the health professions board of such\n\t\t\t\tStates reviewing and expanding prescribing authorities of providers,\n\t\t\t\tsuch as advance practice nurses and physician's assistants, in order to\n\t\t\t\tcontrol the abuse of prescription drugs or other controlled substances with respect to specific drugs and other controlled substances, as\n\t\t\t\tappropriate.", "@entity-type": "federal-body", "#text": "Administrator of the\n\t\t\t\tHealth Resources and Services Administration", "@entity-id": "7526"}], "#text": "The "}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Expansion of prescribing authority"}, "#text": "\n            ", "@id": "id45362CDE72B64119A31784AAD4AE104D", "@commented": "no"}], "#text": "\n          ", "@id": "id53B5F36C6F174A3B9F06BBB595ADC41A"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "id46A4812F7FF9478C8D364CE1EC518127"}, "#text": "\n      ", "@id": "id02A7CEBF80D04395A5A0F8D37EAB95DE", "@commented": "no"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n      ", "#text": "Prescription\n\t\t\t drug abuse training and screening programs"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t (referred to in this section as the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 202 of the\n\t\t\t Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 812", "@value": "usc/21/812"}, "@parsable-cite": "usc/21/812", "#text": "\n              ", "@legal-doc": "usc"}}, "quote": {"#tail": ") shall award\n\t\t\t grants to States to develop continuing education criteria and review processes\n\t\t\t that allow State health profession boards or State agencies to certify\n\t\t\t appropriate education and training for informed and safe prescribing of opioids\n\t\t\t and other drugs on schedule II and III under ", "#text": "Secretary"}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Continuing\n\t\t\t education grants"}, "#text": "\n        ", "@id": "id4317C664C5F14A11A0462550216126B2", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that such\n\t\t\t practitioner has completed continuing medical education\u2014", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, "#text": "A practitioner who registers or renews a registration\n\t\t\t under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " shall,\n\t\t\t at the time of registering, certify to the ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 303(f) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303/ss:f"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 823(f)", "@value": "usc/21/823/f"}, "@parsable-cite": "usc/21/823", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Registration\n\t\t\t with DEA"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "in the case of a\n\t\t\t practitioner registering for the first time, with respect to prescription drug\n\t\t\t abuse; and"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "idF6BA5784DD104C36B06263482CE21FC3", "@commented": "no"}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "in the case of a\n\t\t\t practitioner renewing a registration, with respect to medical understanding of\n\t\t\t the proper use of all drugs listed in the schedules under ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 202 of the\n\t\t\t Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 812", "@value": "usc/21/812"}, "@parsable-cite": "usc/21/812", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "id394B64DF9526412E83D34DCBA29257ED", "@commented": "no"}], "#text": "\n        ", "@id": "id9DA31309BA714B7D865C9505B6B68D09", "@commented": "no"}, {"#tail": "\n    ", "text": {"#tail": "\n      ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall require that a practitioner\n\t\t\t registered under ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": " conduct patient screening for potential drug misuse or\n\t\t\t abuse before prescribing a drug listed on schedule II or III under ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 303(f) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303/ss:f"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 823(f)", "@value": "usc/21/823/f"}], "@entity-type": "law-citation", "#text": "\n            "}, {"#tail": ", according to standards established by the applicable State licensing body.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 202\n\t\t\t of the Controlled Substances Act", "@value": "Controlled Substances Act/s:202"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 812", "@value": "usc/21/812"}, "@parsable-cite": "usc/21/812", "#text": "\n              ", "@legal-doc": "usc"}}]}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Screening\n\t\t\t program"}, "#text": "\n        ", "@id": "id241FAC282E8149FFBC735E157714C424", "@commented": "no"}], "#text": "\n      ", "@id": "id3B1CF051EB86408DBD9F989348F3BB40"}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, {"#tail": ",\n\t\t\t shall conduct a review of naloxone to consider whether naloxone should cease to\n\t\t\t be subject to ", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}], "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " and be available as a behind-the-counter drug, in order to increase\n\t\t\t access of such drug to community-based organizations and street outreach\n\t\t\t organizations.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 503(b) of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 353(b)", "@value": "usc/21/353/b"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "6."}, "header": {"#tail": "\n      ", "#text": "FDA review of\n\t\t\t naloxone"}, "#text": "\n      ", "@id": "id60858CCCDC1D4A02A292C02FD5C0F5BB"}, {"#tail": "\n    ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall convene or coordinate with an existing  entity an interagency working group to\n\t\t\t encourage States and local governments to increase opportunities for disposal\n\t\t\t of opiates, such as frequent ", "@entity-type": "federal-body", "#text": "Secretary of\n\t\t\t Health and Human Services", "@entity-id": "7500"}, "quote": {"#tail": " and fixed\n\t\t\t medicine disposal sites at law enforcement public buildings, and to reduce\n\t\t\t opportunities for abuse of opiates, such as establishing opioid dispensing\n\t\t\t limits at hospital emergency departments.", "#text": "take-back programs"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "7."}, "header": {"#tail": "\n      ", "#text": "Prescription\n\t\t\t drug disposal"}, "#text": "\n      ", "@id": "id38A6FAD4B0024EA1AF6EFAF8E446982B"}, {"#tail": "\n  ", "text": {"#tail": "\n    ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall review prescription drug abuse programs and policies\n\t\t\t in Federal agencies and best practices with respect to prescription drug abuse\n\t\t\t programs of the States and, not later than 18 months after the date of\n\t\t\t enactment of this Act, shall issue a report to ", "@entity-type": "federal-body", "#text": "Comptroller General\n\t\t\t of the United States", "@entity-id": "0500"}, {"#tail": " on its findings and\n\t\t\t recommendations on ways to reduce prescription drug abuse.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}], "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "8."}, "header": {"#tail": "\n      ", "#text": "GAO\n\t\t\t report"}, "#text": "\n      ", "@id": "id06F5A4D5A9114DF9812F345DB0F4E417"}], "#text": "\n    "}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-11-06"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S1657 IS: Increasing the Safety of Prescription Drug Use Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}